In contrast, NT-3 expression reduced cellular excitability, did not alter nociceptive sensitivity or elicit hindlimb spasticity, and generated only moderate changes in locomotion that required treadmill assistance and extrinsic stimulation. The gene discussed is NTF3; the disease is Spasticity.